Andrew Moe

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Kimberly Y. Smith, C. Tierney, Katie R. Mollan et al. · Clinical Infectious Diseases · 2013 · 32 citations · Full text

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202

Charles S. Venuto, Katie R. Mollan, Qing Ma et al. · Journal of Antimicrobial Chemotherapy · 2014 · 19 citations · Full text

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol

Andrew Moe, Elizabeth Liow, Andrew Redfern et al. · British Journal of Urology · 2021 · 14 citations · Full text

Adaptation of a MR imaging protocol into a real-time clinical biometric ultrasound protocol for persons with spinal cord injury at risk for deep tissue injury: A reliability study

Jillian M. Swaine, Andrew Moe, William Breidahl et al. · Journal of Tissue Viability · 2017 · 13 citations · Full text

‘One Stop Prostate Clinic’: prospective analysis of 1000 men attending a public same‐day prostate cancer assessment and/or diagnostic clinic

Cynthia Hawks, Andrew Moe, Steve P. McCombie et al. · ANZ Journal of Surgery · 2020 · 10 citations